Vedanta shares rally 14 pc in 5 days; 6.5 pc in a day
The shares of Vedanta on Friday rose 6.5 per cent to Rs 321 a piece on the BSE. In a span of five days, the mining company had rallied nearly 14 per cent on the
Stay updated with breaking news from What Vedanta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The shares of Vedanta on Friday rose 6.5 per cent to Rs 321 a piece on the BSE. In a span of five days, the mining company had rallied nearly 14 per cent on the
The Microbiome Gains Momentum in Cancer Immunotherapy The Microbiome Gains Momentum in Cancer Immunotherapy Vedanta Biosciences develops drugs made from defined bacterial consortia. One of these drugs, a cancer drug called VE800, addresses a challenge that may commonly occur with microbiome-engaging cancer immunotherapeutics. The problem is variability in microbiome signatures. Vedanta’s CEO, Bernat Olle, PhD, says that with cancer, there is no “night and day type of signature” like that seen with Clostridium difficile infections. Olle suggests that overcoming this problem will require...